G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/11/2004	WO2004097036A2 Optical detector for enzyme activation
11/11/2004	WO2004097034A2 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4)
11/11/2004	WO2004097033A1 Serum biomarkers of hepatitis b virus infected liver and methods for detection thereof
11/11/2004	WO2004097010A1 Crystal of pde5, its crystal structure and its use in drug design
11/11/2004	WO2004097008A1 Method of generating and isolating tumour cells
11/11/2004	WO2004096999A2 In vitro translation system
11/11/2004	WO2004096990A2 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	WO2004096989A2 Single chain antigen-binding polypeptides for polymer conjugation
11/11/2004	WO2004096988A2 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance
11/11/2004	WO2004096987A2 A forward mutation assay based on 5-fluorouracil resistance
11/11/2004	WO2004096984A2 Preservation of rna in a biological sample
11/11/2004	WO2004096980A2 Novel polynucleotides encoding soluble polypeptides and methods using same
11/11/2004	WO2004096979A2 Methods and systems for annotating biomolecular sequences
11/11/2004	WO2004096977A2 Crystal structure of homo sapiens adipocyte lipid binding protein and uses thereof
11/11/2004	WO2004096859A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein
11/11/2004	WO2004096855A2 Methods utilising g-protein coupled receptor 54
11/11/2004	WO2004096841A1 Glut-1 as a receptor for htlv envelopes and its uses
11/11/2004	WO2004096835A1 Nematode pppt-like sequences
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096817A1 Solid-phase saccharide sensing compounds
11/11/2004	WO2004096814A1 Polychlorobiphenyl derivatives and assay method using the same
11/11/2004	WO2004096272A2 Methods and compositions for modulating the interaction between adiponectin and its receptor
11/11/2004	WO2004096211A1 Angiotensin ii receptor blockers for preventing the development or progression of microvascular disease due to diabetes
11/11/2004	WO2004096199A2 Regulation of guanine nucleotide exchange factor
11/11/2004	WO2004096153A2 Prostate cancer therapeutics and diagnostics based on conformers of prostatic acid phosphatase
11/11/2004	WO2004096148A2 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
11/11/2004	WO2004096142A2 Alk protein tyrosine kinase, cells and methods embodying and using same
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	WO2004096120A2 Compounds that selectively bind to membranes of apoptotic cells
11/11/2004	WO2004096054A1 Method for detecting pathogenic agents
11/11/2004	WO2004096021A2 Global analysis of transposable elements as molecular markers of cancer
11/11/2004	WO2004096020A2 Method for detection and characterization of pre-malignant transformation
11/11/2004	WO2004096009A2 Differential determination of hemoglobins
11/11/2004	WO2004088304A3 Method and device for utilizing analyte levels to assist in the treatment of diabetes, insulin resistance and metabolic syndrome
11/11/2004	WO2004083374A3 Methods for screening for an antigen for use in a vaccine
11/11/2004	WO2004082456A3 Method for bringing into contact targetted particles and living cells in suspension
11/11/2004	WO2004081506A3 Sealed sensor housing
11/11/2004	WO2004076054A3 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays
11/11/2004	WO2004074836A3 Methods for investigating the specificity of compounds that interact with receptors
11/11/2004	WO2004072636A9 Measuring rate of change of oxygen concentration and intrinsic oxidation rate in a pile of material
11/11/2004	WO2004072306A8 Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents
11/11/2004	WO2004072236A3 Methods and compositions for 3-d sodium dodecyl sulfate-polyacrylamide cube gel electrophoresis
11/11/2004	WO2004071377A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 3a (pde3a)
11/11/2004	WO2004071345A8 A device and method for the determination of lithium ion concentration in a biological fluid
11/11/2004	WO2004069863A3 Constrained hiv v3 loop peptides as immunogens and receptor antagonists
11/11/2004	WO2004068139A3 Improvement of catalytic efficiency and/or specificity of non-native substrates of enzymes
11/11/2004	WO2004065422A3 Cancerous disease modifying antibodies
11/11/2004	WO2004064773A3 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders
11/11/2004	WO2004063349A3 Lysozyme transgenic ungulates
11/11/2004	WO2004053097A3 Chemopreventive and therapeutic aspects of polyphenolic compositions and assays
11/11/2004	WO2004052175A3 Methods for rapid identification of pathogens in humans and animals
11/11/2004	WO2004048973A8 Method of fixing biomolecule on metal support
11/11/2004	WO2004048324A3 Chemokine parc suppresses specific cytokine production
11/11/2004	WO2004043230A3 A method of screening for disorders of glucose metabolism
11/11/2004	WO2004038407A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
11/11/2004	WO2004038367A3 Biological assays using gradients formed in microfluidic systems
11/11/2004	WO2004031144A3 Use of caspase inhibitors as therapeutic agent against radiation-induced injury
11/11/2004	WO2004024941A3 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/11/2004	WO2004020458A3 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
11/11/2004	WO2004020453A3 Functionalized nanoparticles
11/11/2004	WO2004018418A3 Hydrophilic chemiluminescent acridinium labeling reagents
11/11/2004	WO2004015393A3 Spotting pattern for placement of compounds in an array
11/11/2004	WO2004015070A3 Isolation and identification of t cells
11/11/2004	WO2004010108A3 Method for the identification of ligands
11/11/2004	WO2004009773A3 Methods and compositions for activating or inhibiting vegf-d and vegf-c
11/11/2004	WO2003104770A3 A disposable cartridge for characterizing particles suspended in a liquid
11/11/2004	WO2003101394A3 Defensins: use as antiviral agents
11/11/2004	WO2003088125A8 System and method for integrated computer-aided molecular discovery
11/11/2004	WO2003087827A8 Multi-parameter assays including analysis discs and methods relating thereto
11/11/2004	WO2003087051B1 Methods for identifying allosteric sites
11/11/2004	WO2003081261A3 Microdevices having a preferential axis of magnetization and uses thereof
11/11/2004	WO2003079982A3 Gene amplification in cancer
11/11/2004	WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004	WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004	WO2003049595A3 Improved breath collection apparatus
11/11/2004	WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance
11/11/2004	WO2003040695A3 Protein knobs
11/11/2004	WO2003038052A3 Nucleic acid-associated proteins
11/11/2004	WO2003027239A3 Melanin-concentrating hormone receptor antagonist binding protein
11/11/2004	WO2003012068A3 Novel fusion proteins and assays for molecular binding
11/11/2004	US20040226055 Animal model exhibiting pathological conditions of Alzheimer's disease
11/11/2004	US20040225456 Chemical structure identification
11/11/2004	US20040225455 Measurement of nitrogen content in a gas mixture by transforming the nitrogen into a substance detectable with nondispersive infrared detection
11/11/2004	US20040225454 Method and apparatus for determining the mass of portioned units of active substances
11/11/2004	US20040225450 Analysis of substrates exposed to tobacco and components derived from tobacco
11/11/2004	US20040225449 Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
11/11/2004	US20040225448 Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
11/11/2004	US20040225447 Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
11/11/2004	US20040225446 Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
11/11/2004	US20040225445 Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
11/11/2004	US20040225374 Incubation osteogenic cell with animal growth regulator; culturing; screening for bone cell spheroids
11/11/2004	US20040225249 Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
11/11/2004	US20040225230 Small volume in vitro analyte sensor and methods
11/11/2004	US20040225209 Blood sugar level measuring apparatus
11/11/2004	US20040225119 Fluorescent dyes for use as diagnostic/signalling tool in nucleotide sequence analysis
11/11/2004	US20040225118 31 human secreted proteins
11/11/2004	US20040225114 IGF-1 receptor interacting proteins
11/11/2004	US20040225112 Genes encoding single chain human leukocyte antigen E (HLA-E) proteins to prevent natural killer cell-mediated cytotoxicity
11/11/2004	US20040224921 Fluorescent cobalamins and uses thereof
11/11/2004	US20040224915 High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors

1 ... 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 ... 3937